Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: Novel biomarker sources for clinical diagnosis-Reference-Cited by-同舟云学术

Glucose transporter 1 deficiency, AMP-activated protein kinase activation and immune dysregulation in autism spectrum disorder: Novel biomarker sources for clinical diagnosis

Published:2023-12 Issue:12 Volume:30 Page:103849
ISSN:1319-562X
Container-title:Saudi Journal of Biological Sciences
language:en
Short-container-title:Saudi Journal of Biological Sciences

Author:

Al-Bishri Widad M.^ORCID

Publisher

Elsevier BV

Subject

General Agricultural and Biological Sciences

Reference87 articles.

1. Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma;Akintunde;J. Neuroimmunol.,2015

2. Distinct roles of interleukin-17 and T helper 17 cells among autoimmune diseases;Akiyama;J. Transl. Autoimmun.,2021

3. Evaluation of serum 25-hydroxy vitamin D levels in children with autism spectrum disorder;Arastoo;Ital. J. Pediatr.,2018

4. Peripheral biomarkers in Autism: secreted amyloid precursor protein-alpha as a probable key player in early diagnosis;Bailey;Int. J. Clin. Exp. Med.,2008

5. Compound A, a selective glucocorticoid receptor modulator, enhances heat shock protein Hsp70 gene promoter activation;Beck;PLoS One,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder;Neuropharmacology;2024-11

2. IL-17A Cytokine-Regulated Glut1 Expression in Placenta Cells;Current Issues in Molecular Biology;2024-07-12

3. Manganese in autism spectrum disorder and attention deficit hyperactivity disorder: The state of the art;Current Research in Toxicology;2024